Senate Bill 205
116th Congress(2019-2020)
Right Rebate Act of 2019
Introduced
Introduced in Senate on Jan 24, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
205
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Ron Wyden
grade
Oregon
Connecticut
Iowa
Iowa
Michigan
Minnesota
Minnesota
Nevada
New Hampshire
Ohio
Pennsylvania
No Senate votes have been held for this bill.
Summary
Right Rebate Act of 2019
This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly).
January 24, 2019
01/24/2019
Read twice and referred to the Committee on Finance.
01/24/2019
Introduced in Senate
Public Record
Record Updated
Nov 1, 2022 2:47:40 PM